|Dr. Stuart W. Titus||Chairman, CEO, Pres & Acting CFO||N/A||N/A||N/A|
|Mr. Blake N. Schroeder||COO & Exec. VP||N/A||N/A||1978|
|Mr. Dirk Syburra||VP of Data & Technology||N/A||N/A||N/A|
|Mr. Tyler Whatcott||Chief Technology Officer||N/A||N/A||N/A|
|Nicholas R. Massalas||Director of Bus. Devel.||N/A||N/A||N/A|
Medical Marijuana, Inc., an investment holding company, operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries. The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry. It engages in the research and development of cannabinoid-based pharmaceuticals; and marketing and distribution of cannabidiol hemp oil-based products. In addition, the company provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics; and consulting and securities services to businesses and individuals in the legal cannabis industry. Further, it focuses on the treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products. Medical Marijuana, Inc. was formerly known as Hemp Deposit Distribution Corp. and changed its name to Medical Marijuana, Inc. in March, 2011. The company was incorporated in 2003 and is headquartered in Poway, California.
Medical Marijuana, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.